DIMERIX INVESTOR CALL & PRESENTATION
Potential benefits of DMX-200
prolen coupled receptors (GPCR)
Antiviral medications:
Typically effective at
preventing damage caused
by a virus when
administered
within 3-5 days of infection¹
when many are
asymptomatic
DMX-200:
Does not rely on early
inhibition of viral replication
DMX-200 aims to prevent
damaging immune
response regardless of
vaccination or antiviral
treatment
DMX-200:
May be beneficial for
patients with a wide range
of respiratory diseases in
addition to COVID²
Antivirals are usually very
specific for a virus and
sometimes even the
particular strain of the virus¹
Dimerix
22
1.
2.
Brown L et al (2021) Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial: DOI: 10.1186/s13063-021-05139-27
Based on Szabo, et al., 2020; Merad, et al., 2020; Xiong, et al, 2020; Wu, et al., 2021; Chen, et al., 2009; Yong, et al., 2016View entire presentation